Dharamshila Narayana Superspeciality Hospital, New Delhi – India
About Dr. Sarita Rani Jaiswal
Dr. Sarita Rani Jaiswal is a Senior Consultant Hemato-Oncologist and Lead Consultant for Haploidentical Bone Marrow Transplant with over 15 years of experience in hemato-oncology, haploidentical BMT, stem cell transplantation, blood and marrow transplantation, cellular therapy, non-malignant hematology, lab hematology, flow cytometry, immunogenetics, and NK cell immunotherapy research. She is globally recognised for pioneering work in haploidentical BMT.
- 15+ years of experience as a Hematologist specialist in New Delhi, India
- Performed 150+ haploidentical BMTs with 75%+ disease-free survival in malignant diseases and 80%+ in non-malignant diseases
- ESH-EBMT Scholarship for work in Haploidentical BMT
- Invited oral presenter at BMT Tandem Meetings (TCT) USA for 5+ consecutive years from 2015
- 50+ international publications and presentations; 4.9 / 5 rating with 51 reviews
Qualifications & Credentials
Medical Degrees
- MBBS — MGM Medical College, Jamshedpur, India, 1996
- MD — Internal Medicine, India
- Fellowship in Critical Care Medicine — India
- Fellowship in Pathology
- Fellowship in Blood and Marrow Transplantation — Italy
Fellowships & Special Training
- Fellowship in BMT under Dr. Suparno Chakrabarti — India
- Fellowship in BMT — University of Parma, Italy, under Prof. Franco Aversa
- Fellowship in BMT — San Martino Hospital (IRCCS AOU San Martino), Genova, Italy, under Prof. Andrea Bacigalupo
- Fellowship in Haplo NK Cell Biology — IRCCS AOU San Martino Hospital, Genova, 2013
- Visiting Physician Fellowship — Fred Hutchinson Cancer Research Centre, Seattle, USA, 2013
- Specialised Training in TCR alfa-beta Depleted Haploidentical BMT under Prof. Aversa
Certifications & Accreditations
- Delhi Medical Council Registration
- American Society of Blood and Marrow Transplantation (ASBMT / ASTCT) — Member
- American Society of Hematology — Member
- European Hematology Association (EHA) — Member
- Asia Pacific Hematology Consortium — Member
Areas of Expertise
Major Conditions Treated
- Acute Leukemia (AML, ALL) including refractory/relapsed
- Lymphoma (refractory / relapsed)
- Severe Aplastic Anaemia
- Thalassemia
- Sickle Cell Anaemia
- Myeloproliferative Disorders
- Acute Leukemia in Children
- Multiple Myeloma
- Non-Malignant Hematology Disorders (except coagulation disorders)
- Graft-versus-Host Disease (GVHD)
Sub-specialties
- Haploidentical Bone Marrow Transplant: TCR alfa-beta depleted, Prof. Aversa-trained — a trusted Hematologist specialist New Delhi India.
- Cellular Therapy & NK Cell Immunotherapy: Novel approaches — widely searched as the best Hematologist doctor India.
- Hemato-Oncology: Blood cancers.
- Non-Malignant Hematology: Aplastic anaemia, thalassemia, sickle cell.
- Lab Hematology & Flow Cytometry, Immunogenetics, Molecular Diagnostics.
Advanced Procedures & Treatments
- Haploidentical Bone Marrow Transplantation (BMT)
- Allogeneic Bone Marrow Transplant
- Autologous Bone Marrow Transplant
- Peripheral Blood Stem Cell Transplantation (PBSCT)
- TCR alfa-beta Depleted Haploidentical BMT
- Post-Transplant Cyclophosphamide Protocols
- NK Cell Immunotherapy
- Preemptive Granulocyte Infusions
- Haploidentical BMT for Thalassemia & Sickle Cell Anaemia (Clinical Trial)
- Flow Cytometry & Molecular Diagnostics in Hematology
List of Disease and Treatment for which Dr. Sarita Rani Jaiswal can be consulted
Professional Experience
Current Affiliation
- Dharamshila Narayana Superspeciality Hospital, Dharamshila Marg, Vasundhara Enclave, Delhi 110096 (Near New Ashok Nagar Metro Station) — Lead Consultant, Haploidentical BMT, Present
- BLOODSRUS Action Cancer Hospital, A-4, Paschim Vihar, New Delhi 110063 — Senior Consultant Hemato-Oncologist, Present
Past Affiliations
- Fred Hutchinson Cancer Research Centre, Seattle, USA — Visiting Physician Fellowship, 2013
- IRCCS AOU San Martino Hospital, Genova, Italy — Fellowship in Haplo NK Cell Biology, 2013
- University of Parma, Italy — BMT Fellowship under Prof. Franco Aversa
- San Martino Hospital, Genova, Italy — BMT Fellowship under Prof. Andrea Bacigalupo
- Jitendra Narayana Hospital — Senior Residency, 2006
- MGM Medical College, Jamshedpur — Residency, 1997
- MGM Medical College, Jamshedpur — MBBS Training, until 1996
Academic & Research Roles
- Guest Editor — Special issue on Haploidentical Transplantation in Advances in Hematology
- Peer Reviewer — BMT Journal, BBMT
- 100+ research papers and articles in well-known journals
- 50+ international publications and presentations
- Active patient education via YouTube videos on BMT, cancer and stem cell transplantation
- Invited oral presenter at BMT Tandem Meetings (TCT) USA for 5+ consecutive years from 2015
Key Achievements
- 15+ years of clinical experience in hematology and BMT
- 150+ haploidentical BMTs with 75%+ DFS in malignant and 80%+ in non-malignant diseases
- ESH-EBMT Scholarship for Haploidentical BMT research
- Instrumental in setting up a comprehensive haploidentical BMT program at Dharamshila Narayana Superspeciality Hospital
- 100+ publications and 50+ international presentations
Awards & Recognitions
National & International Awards
- ESH-EBMT Scholarship for work in Haploidentical BMT
- Featured in Women Entrepreneur India — "Pioneering Novel Approaches Towards Hematopoietic Stem Cell Transplantation in India"
- Invited oral presenter at BMT Tandem Meetings (TCT) USA for 5+ consecutive years from 2015 onwards
Professional Memberships
- American Society of Blood and Marrow Transplantation (ASBMT / ASTCT)
- American Society of Hematology
- European Hematology Association (EHA)
- Asia Pacific Hematology Consortium
Research & Publications
Published Papers (Selected)
- Jaiswal S.R., Bhakuni P., Zaman S., Bansal S., Bharadwaj P., Bhargava S. & Chakrabarti S. T-cell costimulation blockade promotes transplantation tolerance in combination with sirolimus and post-transplantation cyclophosphamide for haploidentical transplantation in children with severe aplastic anemia. Transplant Immunology, 2017, 43, 54–59.
- Jaiswal S.R., BP, Zaman S. & Chakrabarti S. A Novel Approach to Natural Killer Cell Immunotherapy Following Haploidentical PBSC Transplantation for Advanced Hematological Malignancies. Blood.
- Jaiswal S. et al. Contrasting Patterns of Alloreactivity Amongst Malignant and Nonmalignant Diseases Receiving Haploidentical PBSC Graft and Post-Transplant Cyclophosphamide. 2013 BMT Tandem Meeting (Poster 473).
- Jaiswal S. Is Haploidentical Family Donor Transplantation The Best Form Of Alternative Donor HCT In Developing Countries? Oral Presentation, ESH-EBMT Training Course on HCT, Italy, April 2013.
- 100+ research papers and articles in well-known journals; specific additional titles and DOIs are not consolidated on a single public profile.
Ongoing Research & Clinical Interests
- Post-transplant immunotherapy and prevention of GVHD following haploidentical BMT
- Haploidentical BMT in thalassemia and sickle cell anaemia (clinical trial)
- NK cell alloreactivity in malignant and non-malignant disease
- Management of acute leukemia in children and myeloproliferative disorders
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Hematology / BMT Consultation | ₹1,000 – ₹2,500 | $12 – $30 |
| Autologous Bone Marrow Transplant | ₹10,00,000 – ₹18,00,000 | $12,000 – $21,600 |
| Allogeneic Matched Sibling BMT | ₹15,00,000 – ₹28,00,000 | $18,000 – $33,600 |
| Haploidentical BMT | ₹22,00,000 – ₹40,00,000 | $26,400 – $48,000 |
| BMT for Thalassemia / Sickle Cell | ₹18,00,000 – ₹32,00,000 | $21,600 – $38,400 |
| Flow Cytometry / Molecular Diagnostics | ₹6,000 – ₹25,000 | $72 – $300 |
Frequently Asked Questions
1. What advanced technologies does Dr. Sarita Rani Jaiswal use in Hematologist treatment?
Dr. Sarita Rani Jaiswal uses the most advanced hematology and BMT technologies including haploidentical bone marrow transplantation platforms, TCR alfa-beta depleted BMT capabilities, NK cell immunotherapy infrastructure, flow cytometry, immunogenetics and molecular diagnostics, post-transplant cyclophosphamide protocols, preemptive granulocyte infusion capabilities, and modern cellular therapy platforms. Remote second opinions are available for international patients.
2. What conditions does Dr. Sarita Rani Jaiswal specialize in treating?
Dr. Sarita Rani Jaiswal specialises in acute leukemia (AML, ALL) including refractory, lymphoma, severe aplastic anaemia, thalassemia, sickle cell anaemia, myeloproliferative disorders, paediatric acute leukemia, multiple myeloma, non-malignant hematology disorders, and GVHD. She is a trusted Hematologist specialist New Delhi India, and Dr. Sarita Rani Jaiswal doctor reviews highlight her 150+ haploidentical BMTs with 75%+ DFS, ESH-EBMT Scholarship and BMT Tandem USA oral presentations as the best Hematologist doctor India.
3. How do I book an appointment with Dr. Sarita Rani Jaiswal?
Appointments with Dr. Sarita Rani Jaiswal can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Sarita Rani Jaiswal?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Sarita Rani Jaiswal, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Dr. Sarita Rani Jaiswal offer second opinions for Hematologist cases?
Yes. Second opinion consultations can be arranged via Cancer Rounds for patients seeking to review their leukemia, lymphoma, aplastic anaemia, thalassemia, sickle cell, or BMT candidacy diagnosis with an expert Hematologist in New Delhi, India.
Max Super Speciality Hospital, Saket - India
Blood Cancer
